These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7736525)

  • 21. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM; Nute EJ; Davis JG; Wu C; Lee A; Murali R; Zhang HT; Qian X; Kao CC; Greene MI
    Oncogene; 1998 Mar; 16(9):1197-207. PubMed ID: 9528862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.
    Weiner DB; Nordberg J; Robinson R; Nowell PC; Gazdar A; Greene MI; Williams WV; Cohen JA; Kern JA
    Cancer Res; 1990 Jan; 50(2):421-5. PubMed ID: 1967224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a neu/c-erbB-2 protein-specific activating factor.
    Dobashi K; Davis JG; Mikami Y; Freeman JK; Hamuro J; Greene MI
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8582-6. PubMed ID: 1717981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors.
    Klapper LN; Vaisman N; Hurwitz E; Pinkas-Kramarski R; Yarden Y; Sela M
    Oncogene; 1997 May; 14(17):2099-109. PubMed ID: 9160890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.
    O'Rourke DM; Greene MI
    Immunol Res; 1998; 17(1-2):179-89. PubMed ID: 9479580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
    Drebin JA; Link VC; Stern DF; Weinberg RA; Greene MI
    Cell; 1985 Jul; 41(3):697-706. PubMed ID: 2860972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
    Wada T; Qian XL; Greene MI
    Cell; 1990 Jun; 61(7):1339-47. PubMed ID: 1973074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
    Yarden Y
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2569-73. PubMed ID: 1969636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HER-2/neu story: from oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy.
    Mehigan BJ; Kerin MJ
    Eur J Surg Oncol; 1999 Apr; 25(2):111-2. PubMed ID: 10218450
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
    Bacus SS; Stancovski I; Huberman E; Chin D; Hurwitz E; Mills GB; Ullrich A; Sela M; Yarden Y
    Cancer Res; 1992 May; 52(9):2580-9. PubMed ID: 1373672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
    Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
    Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration by two-color flow cytometry that tyrosine kinase activity is required for down-modulation of the oncogenic neu receptor.
    Brown VI; Shah N; Smith R; Hellman M; Jarett L; Mikami Y; Cohen E; Qian X; Greene MI
    DNA Cell Biol; 1994 Feb; 13(2):193-209. PubMed ID: 7910024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
    Weiner LM; Clark JI; Davey M; Li WS; Garcia de Palazzo I; Ring DB; Alpaugh RK
    Cancer Res; 1995 Oct; 55(20):4586-93. PubMed ID: 7553634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen.
    Kim KM; Shin EY; Moon JH; Heo TH; Lee JY; Chung Y; Lee YJ; Cho HM; Shin SU; Kang CY
    Int J Cancer; 2002 Dec; 102(4):428-34. PubMed ID: 12402315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer.
    McKenzie SJ; DeSombre KA; Bast BS; Hollis DR; Whitaker RS; Berchuck A; Boyer CM; Bast RC
    Cancer; 1993 Jun; 71(12):3942-6. PubMed ID: 8099528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of the human neu protein facilitates down-modulation by monoclonal antibodies.
    van Leeuwen F; van de Vijver MJ; Lomans J; van Deemter L; Jenster G; Akiyama T; Yamamoto T; Nusse R
    Oncogene; 1990 Apr; 5(4):497-503. PubMed ID: 1970152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor.
    DiGiovanna MP; Stern DF
    Cancer Res; 1995 May; 55(9):1946-55. PubMed ID: 7728765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p185neu expression in human lung adenocarcinomas predicts shortened survival.
    Kern JA; Schwartz DA; Nordberg JE; Weiner DB; Greene MI; Torney L; Robinson RA
    Cancer Res; 1990 Aug; 50(16):5184-7. PubMed ID: 1974168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation sensitivity of the commonly used anti-p185neu/erbB2 monoclonal antibody clone 3B5 suggests selective usage of autophosphorylation sites.
    DiGiovanna MP
    Anal Biochem; 1997 Apr; 247(1):167-70. PubMed ID: 9126388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.